EUVIMEDEUVIMED entdecken
Crossref

MCTP1 increases the malignancy of androgen-deprived prostate cancer cells by inducing neuroendocrine differentiation and EMT

Yen-Nien Liu iD, Wei-Yu Chen iD, Hsiu-Lien Yeh iD, Wei-Hao Chen iD, Kuo-Ching Jiang iD, Han-Ru Li iD, Phan Vu Thuy Dung iD, Zi-Qing Chen iD, Wei-Jiunn Lee iD, Michael Hsiao iD, Jiaoti Huang iD, Yu-Ching Wen iD

Science Signaling · 11.06.2024 · 17 (840)

DOI: 10.1126/scisignal.adc9142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, erschienen am 11.06.2024. Verfasst von Yen-Nien Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan. Hauptthemen laut MEDLINE: Cell Differentiation, Epithelial-Mesenchymal Transition, Prostatic Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine prostate cancer (PCa) (NEPC), an aggressive subtype that is associated with poor prognosis, may arise after androgen deprivation therapy (ADT). We investigated the molecular mechanisms by which ADT induces neuroendocrine differentiation in advanced PCa. We found that transmembrane protein 1 (MCTP1), which has putative Ca 2+ sensing function and multiple Ca 2+ -binding C2 domains, was abundant in samples from patients with advanced PCa. MCTP1 was associated with the expression of the EMT-associated transcription factors ZBTB46, FOXA2, and HIF1A. The increased abundance of MCTP1 promoted PC3 prostate cancer cell migration and neuroendocrine differentiation and was associated with SNAI1-dependent EMT in C4-2 PCa cells after ADT. ZBTB46 interacted with FOXA2 and HIF1A and increased the abundance of MCTP1 in a hypoxia-dependent manner. MCTP1 stimulated Ca 2+ signaling and AKT activation to promote EMT and neuroendocrine differentiation by increasing the SNAI1-dependent expression of EMT and neuroendocrine markers, effects that were blocked by knockdown of MCTP1. These data suggest an oncogenic role for MCTP1 in the maintenance of a rare and aggressive prostate cancer subtype through its response to Ca 2+ and suggest its potential as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell DifferentiationEpithelial-Mesenchymal TransitionProstatic NeoplasmsAnimalsHumansMaleMiceAndrogensCalcium SignalingCell Line, TumorCell MovementGene Expression Regulation, NeoplasticHepatocyte Nuclear Factor 3-betaHypoxia-Inducible Factor 1, alpha SubunitNeuroendocrine CellsPC-3 CellsSnail Family Transcription FactorsTranscription FactorsMembrane Proteins

Substanzen

AndrogensHepatocyte Nuclear Factor 3-betaHypoxia-Inducible Factor 1, alpha SubunitSnail Family Transcription FactorsTranscription FactorsFOXA2 protein, humanHIF1A protein, humanMCTP1 protein, humanMembrane ProteinsSNAI1 protein, human

Autor:innen und Institutionen

  • Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
  • Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei 11031, Taiwan.
  • Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Division of Clinical Pharmacy, School of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
  • Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Department of Medical Education and Research, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.

ORCID-Profile: Yen-Nien Liu, Wei-Yu Chen, Hsiu-Lien Yeh, Wei-Hao Chen, Kuo-Ching Jiang, Han-Ru Li, Phan Vu Thuy Dung, Zi-Qing Chen, Wei-Jiunn Lee, Michael Hsiao, Jiaoti Huang, Yu-Ching Wen

Zitieren

APA

Liu, Y. N., Chen, W. Y., Yeh, H. L., Chen, W. H., Jiang, K. C., Li, H. R., Dung, P. V. T., Chen, Z. Q., Lee, W. J., Hsiao, M., Huang, J., & Wen, Y. C. (2024). MCTP1 increases the malignancy of androgen-deprived prostate cancer cells by inducing neuroendocrine differentiation and EMT. Science Signaling, 17(840). https://doi.org/10.1126/scisignal.adc9142

Vancouver

Liu YN, Chen WY, Yeh HL, Chen WH, Jiang KC, Li HR, et al. MCTP1 increases the malignancy of androgen-deprived prostate cancer cells by inducing neuroendocrine differentiation and EMT. Science Signaling. 2024;17(840). doi:10.1126/scisignal.adc9142

BibTeX
@article{Liu2024,
  author = {Liu, Yen-Nien and Chen, Wei-Yu and Yeh, Hsiu-Lien and Chen, Wei-Hao and Jiang, Kuo-Ching and Li, Han-Ru and Dung, Phan Vu Thuy and Chen, Zi-Qing and Lee, Wei-Jiunn and Hsiao, Michael and Huang, Jiaoti and Wen, Yu-Ching},
  title = {MCTP1 increases the malignancy of androgen-deprived prostate cancer cells by inducing neuroendocrine differentiation and EMT},
  journal = {Science Signaling},
  year = {2024},
  volume = {17},
  number = {840},
  doi = {10.1126/scisignal.adc9142}
}
Kostenlos starten →